TECTONIC THERAPEUTIC, INC. Deferred Rent Credit, Current
TECTONIC THERAPEUTIC, INC. (TECX) had Deferred Rent Credit, Current of $0 as of 2022-12-31, per its 10-K filed 2023-03-23.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRentCreditCurrent · last filed 2023-03-23
- 2022-12-31: Deferred Rent Credit, Current $0.00.
- 2022-09-30: Deferred Rent Credit, Current $51.00K.
- 2022-06-30: Deferred Rent Credit, Current $183.00K.
- 2022-03-31: Deferred Rent Credit, Current $214.00K.
| Period end | Deferred Rent Credit, Current |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-23 |
| 2022-09-30 | $51.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $183.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $214.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $262.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $266.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $259.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $248.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $239.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $216.00K 10-Q · filed 2020-11-05 |
| 2019-12-31 | $214.00K 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |